HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Itamochi Selected Research

Keratins (Keratin)

4/2017Establishment and characterization of a novel uterine carcinosarcoma cell line, TU-ECS-1, with mutations of TP53 and KRAS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroaki Itamochi Research Topics

Disease

48Neoplasms (Cancer)
11/2022 - 08/2002
27Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 02/2002
23Carcinoma (Carcinomatosis)
12/2021 - 01/2002
9Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2022 - 12/2003
9Ovarian Epithelial Carcinoma
12/2019 - 05/2004
6Adenocarcinoma
12/2015 - 08/2002
4Mucinous Adenocarcinoma (Mucinous Carcinoma)
12/2021 - 03/2009
4Endometrial Neoplasms (Endometrial Cancer)
01/2020 - 08/2002
3Infections
06/2016 - 02/2002
2Neoplasm Metastasis (Metastasis)
09/2020 - 01/2018
2Nausea
08/2019 - 11/2014
2Vomiting
08/2019 - 11/2014
2Disease Progression
07/2018 - 06/2006
2Endometriosis
01/2015 - 06/2013
2Breast Neoplasms (Breast Cancer)
11/2013 - 07/2005
1Body Weight (Weight, Body)
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
09/2020
1Anorexia
08/2019
1Malnutrition (Nutritional Deficiencies)
08/2019
1Residual Neoplasm
06/2019
1Endometrioid Carcinoma
06/2018
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2018
1Dyspnea (Shortness of Breath)
01/2018
1Leiomyosarcoma
01/2018
1Lymphedema (Milroy Disease)
06/2015
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2015

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2020 - 02/2002
12PlatinumIBA
01/2021 - 01/2002
11Paclitaxel (Taxol)FDA LinkGeneric
11/2022 - 08/2002
11Cisplatin (Platino)FDA LinkGeneric
10/2017 - 01/2002
6Bevacizumab (Avastin)FDA Link
11/2022 - 07/2010
6Biomarkers (Surrogate Marker)IBA
12/2020 - 07/2010
6taxaneIBA
11/2014 - 07/2005
5Carboplatin (JM8)FDA LinkGeneric
11/2022 - 06/2006
4Phosphotransferases (Kinase)IBA
01/2018 - 07/2005
4TOR Serine-Threonine KinasesIBA
03/2014 - 02/2010
3RNA (Ribonucleic Acid)IBA
01/2018 - 11/2013
3Docetaxel (Taxotere)FDA Link
01/2018 - 03/2004
3Irinotecan (Camptosar)FDA LinkGeneric
10/2014 - 03/2012
3Phosphatidylinositols (Phosphatidylinositol)IBA
03/2014 - 12/2007
3Antineoplastic Agents (Antineoplastics)IBA
01/2014 - 06/2002
2MicroRNAs (MicroRNA)IBA
12/2020 - 02/2010
2Chimeric Antigen ReceptorsIBA
10/2017 - 01/2017
2IntegrinsIBA
10/2017 - 01/2017
2Messenger RNA (mRNA)IBA
01/2017 - 02/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 02/2012
2Indicators and Reagents (Reagents)IBA
12/2015 - 08/2002
2Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
05/2015 - 06/2013
2Drug CombinationsIBA
11/2014 - 01/2014
2dactolisibIBA
08/2014 - 03/2014
2nedaplatinIBA
01/2013 - 07/2012
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2012 - 07/2010
2ErbB Receptors (EGF Receptor)IBA
10/2012 - 07/2010
2Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2012 - 07/2010
22- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
07/2012 - 12/2007
22- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
07/2012 - 12/2007
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2012 - 12/2007
2RetinoidsIBA
12/2008 - 02/2008
1pembrolizumabIBA
11/2022
1niraparibIBA
01/2021
1NivolumabIBA
09/2020
1Sunitinib (Sutent)FDA Link
09/2020
1N-(2-chloro-4-pyridyl)-N'-phenylureaIBA
01/2020
1CytokininsIBA
01/2020
1Dual Specificity Phosphatase 6IBA
12/2019
1Long Noncoding RNAIBA
06/2019
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
06/2019
1Mechanistic Target of Rapamycin Complex 1IBA
01/2018
1GemcitabineFDA Link
01/2018
1tyrosine receptor (receptor, tyrosine)IBA
01/2018
1Gold Sodium Thiomalate (Sodium Aurothiomalate)IBA
11/2017
1Aurora Kinase AIBA
10/2017
1Keratins (Keratin)IBA
04/2017
1VimentinIBA
04/2017
1ThyroglobulinFDA Link
01/2017
1Cadherins (E-Cadherin)IBA
01/2017
1Topotecan (Hycamtin)FDA LinkGeneric
10/2016
1farletuzumabIBA
01/2016
1ParaffinIBA
12/2015
1SERPIN-B5 (maspin)IBA
12/2015
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
12/2015
1Threonine (L-Threonine)FDA Link
09/2015
1ProteomeIBA
09/2015
1Cytidine Diphosphate (CDP)IBA
06/2015
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
05/2015

Therapy/Procedure

30Drug Therapy (Chemotherapy)
11/2022 - 01/2002
15Therapeutics
12/2021 - 02/2002
6Hysterectomy
09/2020 - 06/2004
4Lymph Node Excision (Lymph Node Dissection)
10/2016 - 06/2004
3Neoadjuvant Therapy
10/2016 - 04/2014
3Combination Drug Therapy (Combination Chemotherapy)
10/2016 - 03/2009
1Nephrectomy
09/2020
1Radiofrequency Therapy
01/2018
1Immunotherapy
01/2017
1Operative Surgical Procedures
10/2016
1Trachelectomy
10/2016
1Minimally Invasive Surgical Procedures
10/2016
1Aftercare (After-Treatment)
06/2016
1Activities of Daily Living (ADL)
06/2015